Momentum was one of the top-performing factors in 2020. Indeed, the MSCI ACWI Momentum Index did not only significantly beat the MSCI ACWI, but it also outperformed most factor indices. It benefited from its material exposure to mega-cap growth stocks, in particular its large allocation to ‘big tech’. To this end, the MSCI ACWI Momentum and MSCI ACWI Growth Indices had material overweight exposures to seven of the ten largest stocks in the MSCI ACWI: namely Apple, Microsoft Corporation, Amazon, Tesla, Taiwan Semiconductor Manufacturing Company, Alibaba Group Holding and Tencent.1
‘It was not all smooth sailing as the factor navigated an uneven performance path in 2020’
That said, it was not all smooth sailing as the factor navigated an uneven performance path in 2020. Its ride was punctuated by bumpy occasions during periods of strong reversals characterized by growth stocks retreating. From mid-May until early June, during the first half of September, and – most recently – since 9 November 2020, growth stocks lagged the market, significantly reducing the MSCI ACWI Momentum Index’s year-to-date outperformance during those intervals.
In fact, the most evident indication of a value-growth rotation occurred after the announcement of positive phase III clinical trial results for the Pfizer-BioNTech vaccine-candidate in November. Given its heavy tilt towards large-cap growth equities and underweight exposure to smaller-cap value stocks, the MSCI ACWI Momentum Index was severely affected by the news and the subsequent rally of the value factor. Despite that, the style capped off the year as one of the top-performing factors in 2020.
Quite interestingly, we also observed large return dispersions between different momentum strategies over the period. The results are illustrated in Figure 1, where the blue bars depict the 2020 portfolio returns of various momentum signals relative to their long-term expectations.2 The chart shows that the price momentum factor had an outstanding year, exceeding not only its own long-term average, but also outperforming all the other momentum signals.
Apart from the diversification benefits derived from combining different momentum signals, the risk reduction observed stemmed from avoiding large style bets, that typically accompany traditional price momentum. These bets are, on average, unrewarded, and nearly half of the total volatility associated with traditional price momentum strategies can be attributed to them.3
Portfolio construction parameters are another source of significant return dispersion between different momentum approaches. Most notably is the allocation to mega and large-cap stocks versus smaller-cap counterparts. Several studies show that momentum is stronger in mid- to smaller-cap equities. The efficacy of the factor is reinforced by tilting it towards smaller stocks.4
Momentum can, at times, be exposed to significant style and concentration risks. Its current exposure to large-cap growth stocks that trade at lofty valuations is a good example. We believe that a well-diversified portfolio approach across momentum signals is prudent. It avoids concentrated positions and is less affected by the dynamic tilts that traditional price momentum can adopt to other factors, thereby mitigating those risks.
In our view, combining momentum with other factors has been and continues to be an effective way to improve long-term investment outcomes. Although such choices can result in headwinds at times, we believe that being cognizant of momentum’s properties, and taking them into account when designing a momentum or a multi-factor strategy, leads to better performance in the long term.
1Source: MSCI. Data as of 30 November 2020.
2The long-term historical premiums for the five momentum signals are of similar magnitude. Because the signals are not perfectly correlated, the combination results in a stronger and more robust return than any single measure.
3See amongst others: Blitz, D.C., Huij, J. and Martens, M, 2011, “Residual Momentum”, Journal of Empirical Finance.
4More generally, factor premiums manifest themselves more strongly in the mid- and small-cap segments of the market. We discuss these insights in our paper: Blitz, D.C., Lansdorp, S., Roscovan, V. and Vidojevic, M., 2019 “Factor strategies need breadth”, Robeco article. Available upon request.
The Robeco Capital Growth Funds have not been registered under the United States Investment Company Act of 1940, as amended, nor or the United States Securities Act of 1933, as amended. None of the shares may be offered or sold, directly or indirectly in the United States or to any U.S. Person (within the meaning of Regulation S promulgated under the Securities Act of 1933, as amended (the “Securities Act”)). Furthermore, Robeco Institutional Asset Management B.V. (Robeco) does not provide investment advisory services, or hold itself out as providing investment advisory services, in the United States or to any U.S. Person (within the meaning of Regulation S promulgated under the Securities Act).
This website is intended for use only by non-U.S. Persons outside of the United States (within the meaning of Regulation S promulgated under the Securities Act who are professional investors, or professional fiduciaries representing such non-U.S. Person investors. By clicking “I Agree” on our website disclaimer and accessing the information on this website, including any subdomain thereof, you are certifying and agreeing to the following: (i) you have read, understood and agree to this disclaimer, (ii) you have informed yourself of any applicable legal restrictions and represent that by accessing the information contained on this website, you are not in violation of, and will not be causing Robeco or any of its affiliated entities or issuers to violate, any applicable laws and, as a result, you are legally authorized to access such information on behalf of yourself and any underlying investment advisory client, (iii) you understand and acknowledge that certain information presented herein relates to securities that have not been registered under the Securities Act, and may be offered or sold only outside the United States and only to, or for the account or benefit of, non-U.S. Persons (within the meaning of Regulation S under the Securities Act), (iv) you are, or are a discretionary investment adviser representing, a non-U.S. Person (within the meaning of Regulation S under the Securities Act) located outside of the United States and (v) you are, or are a discretionary investment adviser representing, a professional non-retail investor. Access to this website has been limited so that it shall not constitute directed selling efforts (as defined in Regulation S under the Securities Act) in the United States and so that it shall not be deemed to constitute Robeco holding itself out generally to the public in the U.S. as an investment adviser. Nothing contained herein constitutes an offer to sell securities or solicitation of an offer to purchase any securities in any jurisdiction. We reserve the right to deny access to any visitor, including, but not limited to, those visitors with IP addresses residing in the United States.
This website has been carefully prepared by Robeco. The information contained in this publication is based upon sources of information believed to be reliable. Robeco is not answerable for the accuracy or completeness of the facts, opinions, expectations and results referred to therein. Whilst every care has been taken in the preparation of this website, we do not accept any responsibility for damage of any kind resulting from incorrect or incomplete information. This website is subject to change without notice. The value of the investments may fluctuate. Past performance is no guarantee of future results. If the currency in which the past performance is displayed differs from the currency of the country in which you reside, then you should be aware that due to exchange rate fluctuations the performance shown may increase or decrease if converted into your local currency. For investment professional use only. Not for use by the general public.